DB18419InvestigationalGene Therapies
FLT201 is a recombinant adeno-associated viral vector serotype S3 containing codon optimised expression cassette encoding human beta (β)-glucocerebrosidase variant 85 (GCasevar85).
- Code names
- FLT-201
Resolves to
Compound
What you can answer from here — as of April 21, 2026
Which companies are running trials of FLT201, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account